At present writing, all everyone is talking about is whether they’ve gotten their shot or when they’re getting their shot, and where they got it, what kind of shot they’re getting or what kind they would prefer. They are posting on social media about the difficulty of getting an appointment soon enough, close enough to
NEW YORK — Thanks to the ever-growing applications of data analytics technology, chain drug stores have a unique opportunity to create benefits ranging from improved member outcomes to lowered spending. While the situation is evolving and the trail to driving better member health and reducing costs is still being blazed, chain pharmacies are recognizing the
Abuse of prescription opioid drugs is a significant contributor to the opioid epidemic that has struck across the United States. Prescription misuse plays a major role in the 115 daily overdose deaths and the overall economic burden of $78.5 billion per year. Addressing this issue is vital from both policy and analysis standpoints. That’s especially
CVS Health’s announcement that it would acquire Aetna for $69 billion is only one of recent health care services deals — which totaled $72 billion in 2016 and $76 billion after the third quarter of 2017, prior to CVS announcing the final deal. Across the industry, companies are increasingly leveraging these strategic partnerships to improve
While there are many similarities between retail pharmacies and other retail businesses, two key factors provide a unique opportunity to improve operations and financial efficiency, in turn enabling better patient outcomes. The ability to develop close relationships with other players in the health care industry value chain, and the opportunity to utilize relevant data in
